- $44.85m
- $23.18m
- $17.32m
- 63
- 39
- 81
- 64
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 31.3 | 29.7 | 33.6 | 19.8 | 17.3 |
Cost of Revenue | |||||
Gross Profit | 24.2 | 21.4 | 24.2 | 16.8 | 14.8 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 37.7 | 39.4 | 44.8 | 30 | 25 |
Operating Profit | -6.4 | -9.73 | -11.1 | -10.2 | -7.69 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -13.5 | -17.6 | -11.2 | -10 | -6.99 |
Provision for Income Taxes | |||||
Net Income After Taxes | -13.6 | -17.6 | -11.2 | -9.92 | -7.01 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -13.6 | -17.6 | -11.2 | -13.7 | -4.85 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -13.6 | -17.6 | -11.2 | -13.7 | -4.85 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.737 | -0.785 | -0.444 | -0.394 | -0.274 |